Bio-Rad Laboratories, Inc.
BIO

$9.18 B
Marketcap
$327.47
Share price
Country
$1.53
Change (1 day)
$387.99
Year High
$262.12
Year Low
Categories

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

marketcap

P/E ratio for Bio-Rad Laboratories, Inc. (BIO)

P/E ratio as of 2023: -14.80

According to Bio-Rad Laboratories, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -14.80. At the end of 2022 the company had a P/E ratio of -3.45.

P/E ratio history for Bio-Rad Laboratories, Inc. from 1985 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 -14.80
2022 -3.45
2021 5.30
2020 4.55
2019 6.28
2018 19.19
2017 61.69
2016 190.80
2015 35.78
2014 39.18
2013 45.42
2012 17.56
2011 15.11
2010 15.49
2009 18.28
2008 22.81
2007 29.77
2006 21.08
2005 20.91
2004 21.63
2003 19.24
2002 14.33
2001 17.66
2000 12.49
1999 24.19
1998 10.60
1997 19.64
1996 14.08
1995 13.72
1994 14.36
1993 28.99
1992 8.72
1991 19.08
1990 13.55
1989 12.17
1988 13.65
1987 14.95
1986 20.54
1985 23.51